Oral Session 1-7B Malignant Lymphoma: Clinical Trials and Observation Studies

[OS1-7B-2] Reduced-intensity immunochemotherapy without vincristine in patients over 80 years old with DLBCL

Ilseung Choi¹, Yasuhiko Miyata², Isao Yoshida³, Yoko Suehiro¹, Yukio Hirabayashi⁴, Michihiro Hidaka⁵, Takuya Komeno⁶, Terutoshi Hishita⁷, Hironori Ueno⁸, Kazutaka Sunami⁹, Yuko Ogata¹⁰, Hiromi Iwasaki¹¹, Shinichiro Yoshida¹², Mitsutoshi Kurosawa¹³, Akiko Saito¹⁴, Hirokazu Nagai^2,14 (1.Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, 2.Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan, 3.Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan, 4.Hematology, National Hospital Organization Matsumoto Medical Center, Matsumoto, Japan, 5.Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan, 6.Hematology, National Hospital Organization Mito Medical Center, Ibaraki, Japan, 7.Hematology, National Hospital Organization Himeji Medical Center, Himeji, Japan, 8.Hematology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan, 9.Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan, 10.Hematology, National Hospital Organization Nishibeppu Hospital, Beppu, Japan, 11.Hematology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan, 12.Hematology, National Hospital Organization Nagasaki Medical Center, Omura, Japan, 13.Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan, 14.Clinical Rresarch Center, National Hospital Organization Nagoya Medical Center, Japan)